Kwality Wall’s to Serve Only Milk-Based Ice Cream in India by 2027

Date:

Share post:

Kwality Wall’s, one of India’s most recognised frozen treats brands, has confirmed a full transition away from vegetable fat-based frozen desserts to genuine milk-based ice creams — across its entire Indian portfolio — by 2027. Nearly half of its product range will make the switch within this year itself, with the remainder completing the journey by next year.

“We are not a frozen dessert company anywhere in the world — we are an ice cream company. In India, we changed everything. Everything.”— Peter ter Kulve, Global CEO, The Magnum Ice Cream Company

For decades, a large share of Kwality Wall’s products sold in India used vegetable fats — particularly palm oil — rather than dairy fat. Under Indian food regulations, only products using milk-derived fat qualify as “ice cream.” Everything else is classified as a “frozen dessert.” This distinction has quietly shaped what millions of Indians have been consuming without always realising it.

The company — now operating under The Magnum Ice Cream Company after its separation from Hindustan Unilever in 2025 — sees India as a cornerstone growth market, currently a $200 million business it expects will become its largest globally. Popular products including Magnum, Cornetto, and the core Kwality Wall’s range will all come under the new dairy-first standard. In a move that surprised many in the industry, the brand also plans to reduce prices by up to 30% in select categories — proving that going premium in ingredients does not always mean going dearer for the buyer. Local Indian flavours such as kulfi and kesar bhog are also in the pipeline.

This development is a clear signal to Indian consumers: read the label, know what you are buying — and from 2027, when it says Kwality Wall’s, it will mean real ice cream.

Written by: Sharon Bose & Arundhuti Chatterjee

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...